Companies: 10,795·Total market cap: $144.5T
Avenue Therapeutics, Inc.

Avenue Therapeutics, Inc.

ATXIOTCHealthcare● Active
$0.33
$-0.02(-6.62%)
Market Cap$1087339
P/E Ratio
52W High$0.9699
52W Low$0.15
Overview

Avenue Therapeutics, Inc. (ATXI) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ATXI · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.53atxi eps ttm · atxi earnings per shareEarnings history
PE Ratio (TTM)atxi pe ratio ttm · atxi price to earningsPE Ratio deep dive
Revenue (TTM)$1.4Matxi revenue ttm · atxi annual revenueFull revenue history
Dividend YieldNo Dividenddoes atxi pay dividends · atxi dividend yieldDividend history
Shares Outstanding3.1Matxi shares outstanding · atxi floatShares outstanding history
Next EarningsAug 10, 2026Est.atxi earnings date · atxi next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$1.4M
202320242025
avenue therapeutics, inc. revenue · atxi revenue 2025
FY 2025Net Income-$2.9M▲ +75.03% YoY
202320242025
avenue therapeutics, inc. net income · atxi profit 2025
FY 2025EPS$-0.93▼ 3.33% YoY
202320242025
atxi eps · avenue therapeutics, inc. earnings per share 2025
TTM:Revenue: $1.4MNet Income: -$1.8MEPS: $-0.53View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy1 analystsis atxi a buy · atxi analyst rating
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$12.00Low
$0.33Current
$12.00Avg Target3536.36% upside
$12.00High
atxi price target · atxi 12 month forecast

Total: 1 · Buy rate: 100.0%

The ATXI analyst consensus is Buy, based on ratings from 1 Wall Street analysts over the past 3 months. The average 12-month price target is $12.00, representing +3536.36% upside from the current price of $0.33.

Stock Performance

Full History
1D-12.06%
1W+3.33%
1M-41.51%
3M+40.91%
YTD-54.43%
1Y+54.46%
5Y-99.99%

About Avenue Therapeutics, Inc.

CEOAlexandra MacLean
IPO DateJun 27, 2017
Employees2
CountryUS

Avenue Therapeutics, Inc. functions as a specialized pharmaceutical enterprise, primarily dedicated to innovating and bringing to market medical therapies tailored for critical and intensive care envi…

what is avenue therapeutics, inc. · atxi stock overview · avenue therapeutics, inc. company profile · who is avenue therapeutics, inc. ceo · atxi OTC · avenue therapeutics, inc. headquarters · avenue therapeutics, inc. business segments

About Stock Overview & Key Data

Avenue Therapeutics, Inc. (ATXI) is a Healthcare company in the Biotechnology industry, listed on OTC since Jun 27, 2017. As of the latest trading session, ATXI stock price is $0.33, with a market capitalization of $1.0M. The stock has returned +54.46% over the past 12 months and -54.43% year-to-date.

According to 1 Wall Street analysts, the consensus rating for Avenue Therapeutics, Inc. stock is Buy, with an average 12-month price target of $12.00. In fiscal year 2025, Avenue Therapeutics, Inc. reported revenue of $1.4M and net income of -$2.9M. For detailed data — including Avenue Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Avenue Therapeutics, Inc. (ATXI) stock price is $0.33. The stock is traded on OTC under the ticker symbol ATXI. The 52-week range is $0.15 – $0.97.

ATXI stock priceATXI quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice